These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10102534)

  • 21. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
    Saló J; Caballería L; Bruguera M; Parés A; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune cholangitis.
    Heathcote EJ
    Clin Liver Dis; 1998 May; 2(2):303-11, viii-ix. PubMed ID: 15560034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
    Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
    Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.
    Juliusson G; Imam M; Björnsson ES; Talwalkar JA; Lindor KD
    Scand J Gastroenterol; 2016; 51(6):745-52. PubMed ID: 26776319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis.
    Tang L; Zhong R; He X; Wang W; Liu J; Zhu Y; Li Y; Hou J
    J Gastroenterol Hepatol; 2017 Mar; 32(3):659-666. PubMed ID: 27529417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial primary biliary cirrhosis and autoimmune cholangitis.
    Agarwal K; Jones DE; Watt FE; Burt AD; Floreani A; Bassendine MF
    Dig Liver Dis; 2002 Jan; 34(1):50-2. PubMed ID: 11930900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis.
    Tanaka A; Miyakawa H; Luketic VA; Kaplan M; Storch WB; Gershwin ME
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):295-9. PubMed ID: 12030434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
    Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
    J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
    Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
    J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic features of primary biliary cirrhosis in AMA-positive and AMA-negative patients.
    Fujioka S; Yamamoto K; Okamoto R; Miyake M; Ujike K; Shimada N; Terada R; Miyake Y; Nakajima H; Piao CY; Iwasaki Y; Tanimizu M; Tsuji T
    Endoscopy; 2002 Apr; 34(4):318-21. PubMed ID: 11932789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging drugs for the treatment of Primary Biliary Cholangitis.
    Ali AH; Tabibian JH; Carey EJ; Lindor KD
    Expert Opin Emerg Drugs; 2016; 21(1):39-56. PubMed ID: 26901615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
    Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
    Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Tevini J; Strebinger G; Niederseer D; Pohla-Gubo G; Huber-Schönauer U; Ruhaltinger S; Paulweber B; Datz C; Felder TK; Aigner E
    J Intern Med; 2020 Apr; 287(4):395-404. PubMed ID: 31802567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.
    Saverino D; Pesce G; Antola P; Porcelli B; Brusca I; Villalta D; Tampoia M; Tozzoli R; Tonutti E; Alessio MG; Bagnasco M; Bizzaro N
    PLoS One; 2014; 9(11):e112509. PubMed ID: 25383768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of primary biliary cirrhosis in Chinese patients without serum anti-mitochondrial antibody.
    Li CP; Hwang SJ; Chan CY; Lee FY; Huang YS; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):334-40. PubMed ID: 9294912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimitochondrial antibody-negative primary biliary cirrhosis.
    Hirschfield GM; Heathcote EJ
    Clin Liver Dis; 2008 May; 12(2):323-31; viii-ix. PubMed ID: 18456183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid.
    Sakauchi F; Mori M; Zeniya M; Toda G
    J Epidemiol; 2006 Jan; 16(1):30-4. PubMed ID: 16369106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies].
    Antonio Olivera M; Zapata L; Kaplan M; Bobadilla J; Corte G; de la Mora G; Uribe M; Cabiedes J; Dehesa M; Kershenobich D
    Rev Gastroenterol Mex; 1993; 58(3):220-2. PubMed ID: 8165399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.
    Dahlqvist G; Gaouar F; Carrat F; Meurisse S; Chazouillères O; Poupon R; Johanet C; Corpechot C;
    Hepatology; 2017 Jan; 65(1):152-163. PubMed ID: 27688145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis.
    Masuda J; Omagari K; Matsuo I; Kinoshita H; Sakimura K; Hazama H; Ohba K; Isomoto H; Murase K; Murata I; Kohno S
    J Gastroenterol Hepatol; 2001 Feb; 16(2):239-43. PubMed ID: 11207911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.